DYDe-Ming Yang

De-Ming Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


De-Ming Yang has a total of 302 co-authors. Here are the top co-authors by number of shared publications:

  • Lung-Sen Kao

    National Yang-Ming University

    9 shared publications
  • Yu-Fen Chang

    Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli, 350, Taiwan; LumiSTAR Biotechnology, Inc., National Biotechnology Research Park, Taipei, 115, Taiwan; Core Facilities for Translational Medicines, BioTReC, Academia Sinica, Taipei, 115, Taiwan

    8 shared publications
  • Mong-Lien Wang

    Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC

    7 shared publications
  • Chin-Tien Wang

    Laboratory of Molecular Virology, Basic Research Division, Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC

    6 shared publications
  • Tai-Jay Chang

    Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC

    6 shared publications
  • Chien-Chang Huang

    Syncell Inc., Taipei, Taiwan

    5 shared publications

Latest Publications

  • Corrigendum to “AI-automated portable FRET platform for ultra-sensitive and rapid on-site lead sensing using a bacterial biosensor” [Biosens. Bioelectr. 313, (2016), 119121]

    by Yu-Sheng Liu, Pei-Yun Xie, Hung-Chi Hsu, Wei-Qun Lai, Yu-Fen Chang, Pei-Ying Chiang, Yu-Ling Chiang, Chia-Yi Su, Meng-Jer Wu, De-Ming Yang

  • AI-automated portable FRET platform for ultra-sensitive and rapid on-site lead sensing using a bacterial biosensor

    by Yu-Sheng Liu, Pei-Yun Xie, Hung-Chi Hsu, Wei-Qun Lai, Yu-Fen Chang, Pei-Ying Chiang, Yu-Ling Chiang, Chia-Yi Su, Meng-Jer Wu, De-Ming Yang

  • Open Access

    AI-Automated Portable FRET Platform for Ultra-Sensitive and Rapid On-Site Bacterial Lead Sensing

    by Yu-Sheng Liu, Pei-Yun Xie, Hung-Chi Hsu, Wei-Qun Lai, Yu-Fen Chang, Pei-Ying Chiang, Yu-Ling Chiang, Chia-Yi Su, Meng-Jer Wu, De-Ming Yang

    Rapid on-site monitoring of lead (Pb) contamination is often limited by the fragility of mammalian-cell biosensors in an environmental setting and the manual image analysis that is labor intensive. This work demonstrates a stable, on-site portable sensing platform based on E. coli that expresses the high-sensitivity Met-lead 1.44 M1 FRET sensor and is encapsulated in a protective gelatin hydrogel matrix. To address data processing constraints, we present a novel AI-assisted pipeline combining feature extraction and Cellpose-SAM DL segmentation. This procedure for automated pixel-shift correction and high-accuracy ROI determination (with average precision, AP of 0.945 at threshold intersection over unit, IoU of 0.5) is integrated in this work allowing us to speed up analysis time drastically by a factor of over 30 compared to laborious manual processing. Our bacterial sensor has a high linearity (R2 > 0.97) and it performs consistently well in both aqueous and hydrogel forms. More importantly, the system exhibited a LOD of 2.0 ppb within 15 min, which is significantly below the WHO drinking water limit (10 ppb), and also all the functions remained intact after 4 h of warm environmental exposure. This AI-powered method can be used for both smartphone and microscopy imaging, allowing for real-time detection in a range of applications. Finally, a predictive “traffic-light” risk model was implemented for an easy interpretation of water quality. By closing the gap between laboratory-based sensing and field operation, this work provides a high throughput, real time, mobile solution for next generation environmental safety monitoring.

  • Open Access

    Structure-based approaches against COVID-19

    by Ta-Chou Huang, Kung-Hao Liang, Tai-Jay Chang, Kai-Feng Hung, Mong-Lien Wang, Yen-Fu Cheng, Yi-Ting Liao, De-Ming Yang

    The coronavirus disease 2019 (COVID-19) pandemic has had a major impact on human life. This review highlights the versatile roles of both classical and modern structure-based approaches for COVID-19. X-ray crystallography, nuclear magnetic resonance spectroscopy, and cryogenic electron microscopy are the three cornerstones of classical structural biology. These technologies have helped provide fundamental and detailed knowledge regarding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the related human host proteins as well as enabled the identification of its target sites, facilitating the cessation of its transmission. Further progress into protein structure modeling was made using modern structure-based approaches derived from homology modeling and integrated with artificial intelligence (AI), facilitating advanced computational simulation tools to actively guide the design of new vaccines and the development of anti-SARS-CoV-2 drugs. This review presents the practical contributions and future directions of structure-based approaches for COVID-19.


  • Open Access

    Portable sensing devices for smart healthcare and prevention of lead poisoning

    by Wei-Qun Lai, Ta-Chou Huang, Kung-Hao Liang, Yu-Fen Chang, De-Ming Yang

    Lead (Pb) poisoning can damage human bodies silently, without specific symptoms or conspicuous warning signs. To provide safe and user-friendly tools for detecting heavy metals at low concentrations, scientists have developed and optimized versatile biosensors. To practically employ the developed biosensors specific for Pb (eg, the optimized Met-lead 1.44 M1), smartphone applications designed for user convenience and are easily operable for the on-site detection of Pb in environmental water, drinking water, food, and blood/urine are urgently needed. To establish a monitoring system for home health maintenance, a portable device and useful apps installed on a smartphone can be integrated, and the data acquired can be sent to and stored in the cloud for further analysis and evidence preservation. With the high transmissions speeds for 4G and 4G wireless Internet, such a system can be applied for health protection; water-quality data can be provided by anyone and publicly shared for display on smartphone interfaces, alerting individuals of heavy metal contamination. In this review, we describe recent developments in heavy metal–sensing devices, including home health maintenance systems, which have been successfully and practically applied to prevent heavy metal Pb poisoning.


  • Open Access

    Smart healthcare: A prospective future medical approach for COVID-19

    by De-Ming Yang, Tai-Jay Chang, Kai-Feng Hung, Mong-Lien Wang, Yen-Fu Cheng, Su-Hua Chiang, Mei-Fang Chen, Yi-Ting Liao, Wei-Qun Lai, Kung-Hao Liang

    COVID-19 has greatly affected human life for over 3 years. In this review, we focus on smart healthcare solutions that address major requirements for coping with the COVID-19 pandemic, including (1) the continuous monitoring of severe acute respiratory syndrome coronavirus 2, (2) patient stratification with distinct short-term outcomes (eg, mild or severe diseases) and long-term outcomes (eg, long COVID), and (3) adherence to medication and treatments for patients with COVID-19. Smart healthcare often utilizes medical artificial intelligence (AI) and cloud computing and integrates cutting-edge biological and optoelectronic techniques. These are valuable technologies for addressing the unmet needs in the management of COVID. By leveraging deep learning/machine learning capabilities and big data, medical AI can perform precise prognosis predictions and provide reliable suggestions for physicians’ decision-making. Through the assistance of the Internet of Medical Things, which encompasses wearable devices, smartphone apps, internet-based drug delivery systems, and telemedicine technologies, the status of mild cases can be continuously monitored and medications provided at home without the need for hospital care. In cases that develop into severe cases, emergency feedback can be provided through the hospital for rapid treatment. Smart healthcare can possibly prevent the development of severe COVID-19 cases and therefore lower the burden on intensive care units.


  • Open Access

    SARS-CoV-2 vaccines in children and adolescents: Can immunization prevent hospitalization?

    by Kung-Hao Liang, Kai-Feng Hung, Mong-Lien Wang, Tai-Jay Chang, Yen-Fu Cheng, Su-Hua Chiang, Mei-Fang Chen, Yi-Ting Liao, Shih-Hwa Chiou, De-Ming Yang

    The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants of concern can infect people of all ages and can cause severe diseases in children, such as encephalitis, which require intensive care. Therefore, vaccines are urgently required to prevent severe disease in all age groups. We reviewed the safety and efficacy profiles of mRNA vaccines—BNT162b2 and mRNA-1273—demonstrated by clinical trials or observed in the real world. mRNA-1273 is effective in preventing SARS-CoV-2 infection in preschool children (6 months-6 years old). Both BNT162b2 and mRNA-1273 are effective in preventing SARS-CoV-2 infection in school-aged children and adolescents, thereby preventing post-coronavirus disease (COVID) conditions. The common side effects of vaccination are pain at the injection site, fatigue, and headache. Myocarditis and pericarditis are uncommon. Monitoring post-vaccination troponin levels may help prevent severe cardiac events. The SARS-CoV-2 coronavirus mutates its genome to overcome the herd immunity provided by mass vaccinations; therefore, we may need to develop new generations of vaccines, such as those using viral nucleocapsid proteins as antigens. In conclusion, the mRNA vaccines are generally safe and effective in preventing severe diseases and hospitalization among children and adolescents.


  • Open Access

    Nitric Oxide Mobilizes Intracellular Zn2+ via the GC/cGMP/PKG Signaling Pathway and Stimulates Adipocyte Differentiation

    by Chien-Wei Chen, Luen-Kui Chen, Tai-Ying Huang, De-Ming Yang, Shui-Yu Liu, Pei-Jiun Tsai, Tien-Hua Chen, Heng-Fu Lin, Chi-Chang Juan

    Plasma and tissue zinc ion levels are associated with the development of obesity. Previous studies have suggested that zinc ions may regulate adipocyte metabolism and that nitric oxide (NO) plays a pivotal role in the regulation of adipocyte physiology. Our previous study showed that chronic NO deficiency causes a significant decrease in adipose tissue mass in rats. Studies also suggested that zinc ions play an important modulatory role in regulating NO function. This study aims to explore the role of zinc ions in NO-regulated adipocyte differentiation. We hypothesized that NO could increase intracellular Zn2+ level and then stimulate adipocyte differentiation. ZnCl2 and the NO donor, NONOate, were used to explore the effects of Zn2+ and NO on adipocyte differentiation. Regulatory mechanisms of NO on intracellular Zn2+ mobilization were determined by detection. Then, Zn2+-selective chelator TPEN was used to clarify the role of intracellular Zn2+ on NO-regulated adipocyte differentiation. Furthermore, the relationship between adipocyte size, Zn2+ level, and NOS expression in human subcutaneous fat tissue was elucidated. Results showed that both ZnCl2 and NO stimulated adipocyte differentiation in a dose-dependent manner. NO stimulated intracellular Zn2+ mobilization in adipocytes through the guanylate cyclase (GC)/cyclic guanosine monophosphate (cGMP)/protein kinase G (PKG) pathway, and NO-stimulated adipocyte differentiation was Zn2+-dependent. In human subcutaneous adipose tissue, adipocyte size was negatively correlated with expression of eNOS. In conclusion, NO treatment stimulates intracellular Zn2+ mobilization through the GC/cGMP/PKG pathway, subsequently stimulating adipocyte differentiation.


  • Open Access

    Portable FRET-Based Biosensor Device for On-Site Lead Detection

    by Wei-Qun Lai, Yu-Fen Chang, Fang-Ning Chou, De-Ming Yang

    Most methods for measuring environmental lead (Pb) content are time consuming, expensive, hazardous, and restricted to specific analytical systems. To provide a facile, safe tool to detect Pb, we created pMet-lead, a portable fluorescence resonance energy transfer (FRET)-based Pb-biosensor. The pMet-lead device comprises a 3D-printed frame housing a 405-nm laser diode—an excitation source for fluorescence emission images (YFP and CFP)—accompanied by optical filters, a customized sample holder with a Met-lead 1.44 M1 (the most recent version)-embedded biochip, and an optical lens aligned for smartphone compatibility. Measuring the emission ratios (Y/C) of the FRET components enabled Pb detection with a dynamic range of nearly 2 (1.96), a pMet-lead/Pb dissociation constant (Kd) 45.62 nM, and a limit of detection 24 nM (0.474 μg/dL, 4.74 ppb). To mitigate earlier problems with a lack of selectivity for Pb vs. zinc, we preincubated samples with tricine, a low-affinity zinc chelator. We validated the pMet-lead measurements of the characterized laboratory samples and unknown samples from six regions in Taiwan by inductively coupled plasma mass spectrometry (ICP-MS). Notably, two unknown samples had Y/C ratios significantly higher than that of the control (3.48 ± 0.08 and 3.74 ± 0.12 vs. 2.79 ± 0.02), along with Pb concentrations (10.6 ppb and 15.24 ppb) above the WHO-permitted level of 10 ppb in tap water, while the remaining four unknowns showed no detectable Pb upon ICP-MS. These results demonstrate that pMet-lead provides a rapid, sensitive means for on-site Pb detection in water from the environment and in living/drinking supply systems to prevent potential Pb poisoning.


  • Open Access

    Portable FRET-Based Biosensor Device for On-Site Lead Detections

    by Wei-Qun Lai, Yu-Fen Chang, Fang-Ning Chou, De-Ming Yang

    Most methods for measuring environmental lead (Pb) content are time consuming, expensive, hazardous, and restricted to specific analytical systems. To provide a facile, safe tool to detect Pb, we created pMet-lead, a portable fluorescence resonance energy transfer (FRET)-based Pb biosensor. pMet-lead comprises a 3D-printed frame housing a 405-nm laser diode — an excitation source for fluorescence emission images (YFP and CFP) — accompanied by optical filters, a customized sample holder with a Met-lead 1.44 M1 (the most recent version)-embedded biochip, and an optical lens aligned for smartphone compatibility. Measuring the emission ratios (Y/C) of the FRET component enables Pb detection with a dynamic range of nearly 2 (1.96), pMet-lead/Pb dissociation constant (Kd) 45.62 nM, and limit of detection 40 nM (0.832 μg/dL, 8.32 ppb). To mitigate earlier problems with lack of selectivity for Pb vs. zinc, we preincubated samples with tricine, a low-affinity zinc chelator. We validated pMet-lead measurements of characterized laboratory samples and unknown samples from six regions in Taiwan by inductively coupled plasma mass spectrometry (ICP-MS). Notably, two unknowns had Y/C ratios significantly higher than that of the control (3.48 ± 0.08 and 3.74 ± 0.12 vs. 2.79 ± 0.02), along with Pb concentrations (10.6 ppb and 15.24 ppb) above the WHO-permitted level of 10 ppb in tap water, while the rest four unknowns showing no detectable Pb upon ICP-MS. These results demonstrate that pMet-lead provides a rapid, sensitive means for on-site Pb detection in water from the environment and in living/drinking supply systems to prevent potential Pb poisoning.